Status: current, Defined. Date: 31-Jan 2022. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4664391000168113 | tozinameran 30 microgram / 0.3 mL injection, 2.25 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4664401000168110 | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4664491000168116 | COVID-19 BNT162b2 mRNA adolescent/adult vaccine injection, 2.25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4664501000168111 | BNT162b2 mRNA (messenger ribonucleic acid) encoding SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2) spike glycoprotein 30 microgram/0.3 mL injection, 2.25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
4664511000168114 | BNT162b2 mRNA encoding SARS-CoV-2 spike protein 30 microgram/0.3 mL injection, 2.25 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | Is a | tozinameran | true | Inferred relationship | Some | ||
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | has Australian BoSS | tozinameran | true | Inferred relationship | Some | 608546102 | |
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | has intended active ingredient | tozinameran | true | Inferred relationship | Some | 608546102 | |
tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1900548861 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Comirnaty Grey Cap 12 Years and Above Ready to Use Multidose 30 microgram/0.3 mL injection, 2.25 mL vial | Is a | True | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | Inferred relationship | Some | |
tozinameran 30 microgram/0.3 mL injection, 10 x 2.25 mL vials | has MPUU | True | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | Inferred relationship | Some | 400194692 |
tozinameran 30 microgram/0.3 mL injection, 195 x 2.25 mL vials | has MPUU | True | tozinameran 30 microgram/0.3 mL injection, 2.25 mL vial | Inferred relationship | Some | 1767422615 |
Reference Sets
List of Excluded Medicinal Items reference set
Australian dialect reference set
Medicinal product unit of use reference set